March 2024. Volume 20. Number 1

Favorable cardiovascular outcome in pediatric multisystem inflammatory syndrome linked to SARS-CoV-2

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Yasuhara J, Masuda K, Watanabe K, Shirasu T, Takagi H, Sumitomo N, et al. Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis. Pediatr Cardiol. 2023;44:892-907.

Reviewers: Blanco Rodríguez C1, Albi Rodríguez MS2.
1Pediatra. CS Sanchinarro. Madrid. España.
2Servicio de Neumología y Alergia Infantil. Hospital Universitario 12 de Octubre. Madrid. España.
Correspondence: Carolina Blanco Rodríguez. Email: c_blanco50@hotmail.com
Reception date: 20/12/2023
Acceptance date: 08/01/2024
Publication date: 24/01/2024

Abstract

Authors’ conclusions: in children with systemic inflammatory syndrome associated with SARS-CoV-2 infection, the medium-term cardiac outcome (6 months) has been favorable with resolution of left ventricular systolic dysfunction, although with persistence in a subgroup of patients with coronary anomalies.

Reviewers’ commentary: the satisfactory cardiovascular evolution of pediatric patients affected by systemic inflammatory syndrome associated with SARS-CoV-2 is of high clinical importance and allows establishing a medium-term prognosis for these patients. Up to 5% of patients with coronary involvement may remain with these lesions, so multicenter studies must be carried out to detect patients at risk of persistent lesions and to establish the prognosis in this subgroup of patients.

How to cite this article

Blanco Rodríguez C, Albi Rodríguez MS. Evolución cardiovascular favorable en el síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2. Evid Pediatr. 2024;20:5.

AVC | Critically appraised articles

Yasuhara J, Masuda K, Watanabe K, Shirasu T, Takagi H, Sumitomo N, et al. Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis. Pediatr Cardiol. 2023;44:892-907.

Reviewers: Blanco Rodríguez C1, Albi Rodríguez MS2.
1Pediatra. CS Sanchinarro. Madrid. España.
2Servicio de Neumología y Alergia Infantil. Hospital Universitario 12 de Octubre. Madrid. España.
Correspondence: Carolina Blanco Rodríguez. Email: c_blanco50@hotmail.com
Reception date: 20/12/2023
Acceptance date: 08/01/2024
Publication date: 24/01/2024

How to cite this article

Blanco Rodríguez C, Albi Rodríguez MS. Evolución cardiovascular favorable en el síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2. Evid Pediatr. 2024;20:5.

24/01/2024

Linked Comment